Replimune (REPL)
6.15
-0.18 (2.84%)
Upcoming Events
Latest Headlines
Form SC 13G/A Replimune Group, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
April 10, 2024 12:59 PM - SEC Filing
Form SC 13G/A Replimune Group, Inc. Filed by: STATE STREET CORP
April 10, 2024 9:49 AM - SEC Filing
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Asso
April 7, 2024 5:00 PM - Globe NewsWire
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 4, 2024 8:00 AM - Globe NewsWire
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Peeples-Dyer Veleka
April 3, 2024 8:05 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Patel Sushil
April 3, 2024 8:04 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Pucci Paolo
April 3, 2024 8:03 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Xynos Konstantinos
April 3, 2024 8:03 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Dhingra Kapil
April 3, 2024 8:02 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Hill Emily Luisa
April 3, 2024 8:02 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: SLATTERY JOSEPH P
April 3, 2024 8:01 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Sarchi Christopher
April 3, 2024 8:01 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Oliger Christy J.
April 3, 2024 8:01 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Weinand Dieter
April 3, 2024 8:01 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Levitsky Hyam
April 3, 2024 8:01 PM - SEC Filing
Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Schwendenman Andrew
April 3, 2024 8:01 PM - SEC Filing
Form 8-K Replimune Group, Inc. For: Mar 21
March 26, 2024 7:34 AM - SEC Filing
Replimune (REPL) Appoints Sushil Patel as CEO
March 26, 2024 7:30 AM - StreetInsider
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
March 26, 2024 7:30 AM - Globe NewsWire
Replimune to Present at the American Association for Cancer Research Annual Meeting 2024
March 6, 2024 8:00 AM - Globe NewsWire
Replimune to Present at Three Upcoming Investor Conferences
March 5, 2024 8:01 AM - Globe NewsWire
Replimune Group (REPL) PT Raised to $12 at H.C. Wainwright
February 15, 2024 6:40 AM - StreetInsider
Form SC 13G/A Replimune Group, Inc. Filed by: Omega Fund IV, L.P.
February 14, 2024 4:45 PM - SEC Filing
Form SC 13G/A Replimune Group, Inc. Filed by: Redmile Group, LLC
February 14, 2024 4:27 PM - SEC Filing
Form SC 13G/A Replimune Group, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
February 14, 2024 10:04 AM - SEC Filing
Form SC 13G/A Replimune Group, Inc. Filed by: Forbion Capital Fund III Cooperatief U.A.
February 14, 2024 7:22 AM - SEC Filing
Form SC 13G Replimune Group, Inc. Filed by: MORGAN STANLEY
February 9, 2024 12:10 PM - SEC Filing
Replimune Group (REPL) PT Raised to $13 at Piper Sandler
February 8, 2024 2:46 PM - StreetInsider
Replimune Group (REPL) PT Raised to $16 at Wedbush
February 8, 2024 2:40 PM - StreetInsider
Form 10-Q Replimune Group, Inc. For: Dec 31
February 8, 2024 8:10 AM - SEC Filing
Form 8-K Replimune Group, Inc. For: Feb 08
February 8, 2024 8:05 AM - SEC Filing
Replimune Group, Inc. (REPL) Tops Q3 EPS by 12c
February 8, 2024 8:03 AM - StreetInsider
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
February 8, 2024 8:01 AM - Globe NewsWire
Form SC 13G/A Replimune Group, Inc. Filed by: BlackRock Inc.
January 26, 2024 11:52 AM - SEC Filing
Full Article List
